ALONZO ROSS

Summary

Affiliation: University of Massachusetts Medical School
Country: USA

Publications

  1. pmc A novel phosphatidylinositol(3,4,5)P3 pathway in fission yeast
    Prasenjit Mitra
    Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, 364 Plantation St, Rm 819, Worcester, MA 01605, USA
    J Cell Biol 166:205-11. 2004
  2. ncbi request reprint PTEN: a newly identified regulator of neuronal differentiation
    A H Ross
    Department of Biochemistry and Molecular Pharmacology, Worcester, MA 01655, USA
    Neuroscientist 7:278-81. 2001

Collaborators

  • Prasenjit Mitra
  • Monica L Kerr
  • John J Nunnari
  • Gregory M Hendricks
  • Lucia E Rameh
  • Lewis C Cantley
  • Maria P Ivshina
  • Yingjie Zhang
  • Seth J Field
  • Dannel McCollum

Detail Information

Publications2

  1. pmc A novel phosphatidylinositol(3,4,5)P3 pathway in fission yeast
    Prasenjit Mitra
    Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, 364 Plantation St, Rm 819, Worcester, MA 01605, USA
    J Cell Biol 166:205-11. 2004
    ..These studies suggest that a pathway for PI(3,4,5)P3 synthesis downstream of a class III phosphoinositide 3-kinase evolved before the appearance of class I phosphoinositide 3-kinases...
  2. ncbi request reprint PTEN: a newly identified regulator of neuronal differentiation
    A H Ross
    Department of Biochemistry and Molecular Pharmacology, Worcester, MA 01655, USA
    Neuroscientist 7:278-81. 2001
    ....

Research Grants14

  1. Enhancing glioma chemotherapy by suppressing Notch signaling
    Alonzo H Ross; Fiscal Year: 2010
    ..Our goal is to understand the underlying mechanism, identity markers for responsive glioblastomas and translate these observations to the clinic. ..
  2. NERVE GROWTH FACTOR AND NEURONAL DIFFERENTIATION
    ALONZO ROSS; Fiscal Year: 2000
    ..The mechanism by which neurotrophic factors control cell proliferation is directly relevant to neuronal development, neural regeneration, neurodegenerative diseases, and neural tumors. ..
  3. EGFRvIII and PTEN Loss Transform Neural Precursor Cells
    ALONZO ROSS; Fiscal Year: 2009
    ..These experiments will provide a basis for future development of new therapies and drugs to prevent tumor progression. ..
  4. EGFRvIII and PTEN Loss Transform Neural Precursor Cells
    ALONZO ROSS; Fiscal Year: 2006
    ..These experiments will provide a basis for future development of new therapies and drugs to prevent tumor progression. ..
  5. Newly Identified Regulator of Neuronal Differentiation
    ALONZO ROSS; Fiscal Year: 2004
    ..These experiments address how PTEN and, in turn, PIPs regulate development, neuronal survival, neurodegeneration, and development of brain tumors. ..
  6. Newly Identified Regulator of Neuronal Differentiation
    ALONZO ROSS; Fiscal Year: 2003
    ..These experiments address how PTEN and, in turn, PIPs regulate development, neuronal survival, neurodegeneration, and development of brain tumors. ..
  7. Newly Identified Regulator of Neuronal Differentiation
    ALONZO ROSS; Fiscal Year: 2001
    ..These experiments address how PTEN and, in turn, PIPs regulate development, neuronal survival, neurodegeneration, and development of brain tumors. ..
  8. Newly Identified Regulator of Neuronal Differentiation
    ALONZO ROSS; Fiscal Year: 2002
    ..These experiments address how PTEN and, in turn, PIPs regulate development, neuronal survival, neurodegeneration, and development of brain tumors. ..
  9. EGFRvIII and PTEN Loss Transform Neural Precursor Cells
    ALONZO ROSS; Fiscal Year: 2007
    ..These experiments will provide a basis for future development of new therapies and drugs to prevent tumor progression. ..
  10. Enhancing glioma chemotherapy by suppressing Notch signaling
    Alonzo H Ross; Fiscal Year: 2010
    ..Our goal is to understand the underlying mechanism, identity markers for responsive glioblastomas and translate these observations to the clinic. ..
  11. Role of Doublecortin in Glioma Cell Invasiveness
    ALONZO ROSS; Fiscal Year: 2006
    ..It is exploratory and can be completed in two years. The is potentially a big payoff, namely, identification of DCX's role in glioma cell invasiveness and a new target for development of anti-glioma drugs. ..
  12. NERVE GROWTH FACTOR AND NEURONAL DIFFERENTIATION
    ALONZO ROSS; Fiscal Year: 1999
    ..The mechanism by which neurotrophic factors control cell proliferation is directly relevant to neuronal development, neural regeneration, neurodegenerative diseases, and neural tumors. ..